Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
American Journal of Hematology
|
February 18, 2011
Acquired hemophilia: we now see it with myeloproliferative neoplasms
Marina Kremyanskaya, Louis Aledort
Expert Review of Hematology
|
February 5, 2013
Will gene therapy trump factor treatment in hemophilia?
Savita Rangarajan, Louis Aledort
American Journal of Hematology
|
December 22, 2005
Therapeutic decision-making in inhibitor patients
Geoffrey Allen, Louis Aledort
American Journal of Hematology
|
January 26, 2011
Recurrent miscarriages: caution regarding development of clinical trials using low molecular weight heparin and pregnancy
Dipika Misra, Louis Aledort
Expert Opinion on Emerging Drugs
|
March 11, 2005
Therapy for haemophilia: recent advances and goals for the future
Guy Young, Louis Aledort
Blood Reviews
|
March 11, 2004
Prophylactic factor replacement in hemophilia
Manuel D Carcao, Louis Aledort
Thrombosis Research
|
September 21, 2013
The clinical implications of ADAMTS13 function: the perspectives of haemostaseologists
Savita Rangarajan, Craig Kessler, Louis Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 9, 2021
In response to WFH guidelines for the management of haemophilia, 3<sup>rd</sup> edition: Is there a difference between extended-half-life FVIII products or not?
Erik Berntorp, Snejana Krassova, Louis Aledort
American Journal of Hematology
|
December 6, 2011
A case of factor V inhibitor with complete correction of the PT and aPTT upon mixing
Jay Lipshitz, Thandavababu Chelliah, Louis Aledort
Pediatric Blood & Cancer
|
October 31, 2012
Symposium on congenital and acquired bleeding disorders in children (in honor of the lifetime accomplishments of Dr. Victor S. Blanchette in pediatric hematology)
Manuel Carcao, David Malkin, Louis Aledort
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
American Journal of Hematology
|
February 18, 2011
Acquired hemophilia: we now see it with myeloproliferative neoplasms
Marina Kremyanskaya, Louis Aledort
Expert Review of Hematology
|
February 5, 2013
Will gene therapy trump factor treatment in hemophilia?
Savita Rangarajan, Louis Aledort
American Journal of Hematology
|
December 22, 2005
Therapeutic decision-making in inhibitor patients
Geoffrey Allen, Louis Aledort
American Journal of Hematology
|
January 26, 2011
Recurrent miscarriages: caution regarding development of clinical trials using low molecular weight heparin and pregnancy
Dipika Misra, Louis Aledort
Expert Opinion on Emerging Drugs
|
March 11, 2005
Therapy for haemophilia: recent advances and goals for the future
Guy Young, Louis Aledort
Blood Reviews
|
March 11, 2004
Prophylactic factor replacement in hemophilia
Manuel D Carcao, Louis Aledort
Thrombosis Research
|
September 21, 2013
The clinical implications of ADAMTS13 function: the perspectives of haemostaseologists
Savita Rangarajan, Craig Kessler, Louis Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 9, 2021
In response to WFH guidelines for the management of haemophilia, 3<sup>rd</sup> edition: Is there a difference between extended-half-life FVIII products or not?
Erik Berntorp, Snejana Krassova, Louis Aledort
American Journal of Hematology
|
December 6, 2011
A case of factor V inhibitor with complete correction of the PT and aPTT upon mixing
Jay Lipshitz, Thandavababu Chelliah, Louis Aledort
Pediatric Blood & Cancer
|
October 31, 2012
Symposium on congenital and acquired bleeding disorders in children (in honor of the lifetime accomplishments of Dr. Victor S. Blanchette in pediatric hematology)
Manuel Carcao, David Malkin, Louis Aledort
Page
of 3